How Peptide Stacks Work

1. The logic behind stacking

The idea is mechanistic synergy: two peptides that act on different parts of a process (e.g. one promoting tissue formation, another reducing inflammation) might, in theory, do more together than alone. That’s plausible biology — but for most peptide stacks it’s a hypothesis drawn from mechanism, not a result proven by head-to-head human trials.

2. Common combinations

• · BPC-157 + TB-500 — the most-discussed “healing & recovery” pair; both are tied to tissue-repair mechanisms.
• · Ipamorelin + CJC-1295 — growth-hormone secretagogues paired to support GH pulse amplitude (research stage).
• · GHK-Cu + a repair peptide — copper peptide for skin/collagen sometimes paired with BPC-157.

See the /stacks pages for curated combos with sourced notes, or /guides for peptides grouped by goal.

3. Where the risk sits

• · Unknowns multiply. Each compound adds its own side-effect profile and potential interactions, most of them poorly characterized.
• · You can’t tell what’s working. Change one variable at a time, or you can’t attribute an effect (good or bad) to anything.
• · Community dosing lore ≠ evidence. Forum stacks are experiments people ran on themselves, not protocols.
• · Reconstitution + sterility get more error-prone with multiple vials — infection risk scales with technique.

4. A sensible posture

Treat any stack as a hypothesis. Read the per-peptide research first (use the reliability tiers), start with the single best-evidenced compound, and only consider a combination once you understand each component on its own. GLP-1s (semaglutide, tirzepatide) are approved medicines and are not part of any DIY stack.